• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

A regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis & other musculoskeletal disorders, oncology and dermatology diseases.
View the full Corporate Spotlight arrow Created with Sketch.

Regeneus achieves major milestones

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RGS
Still no deal?!?
14/01/19 49 9.5K
14/01/19 Last post  TDA Comments Created with Sketch.  49  Views Created with Sketch.  9.5K 
RGS
Interesting article
07/12/18 6 1.0K
07/12/18 Last post  Dufrane Comments Created with Sketch.  6  Views Created with Sketch.  1.0K 
RGS
RGS (ASX) Corporate Spotlight Updates
03/12/18 2 494
03/12/18 Last post  Corporate Spotlight Comments Created with Sketch.  2  Views Created with Sketch.  494 
RGS 03/12/18 2 759
03/12/18 Last post  happydad Comments Created with Sketch.  2  Views Created with Sketch.  759 
RGS
News: RGS Regeneus Says Chinese Patent Granted For Biomarkers To Monitor Disease Progression For...
03/12/18 0 128
03/12/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  128 
RGS 27/11/18 32 7.6K
27/11/18 Last post  aruc6393 Comments Created with Sketch.  32  Views Created with Sketch.  7.6K 
RGS 22/11/18 4 904
22/11/18 Last post  Biotechasx Comments Created with Sketch.  4  Views Created with Sketch.  904 
RGS 22/11/18 0 163
22/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  163 
RGS 22/11/18 0 194
22/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  194 
RGS 03/11/18 2 643
03/11/18 Last post  TDA Comments Created with Sketch.  2  Views Created with Sketch.  643 
RGS 24/10/18 1 412
24/10/18 Last post  Biotechasx Comments Created with Sketch.  1  Views Created with Sketch.  412 
RGS 24/10/18 0 158
24/10/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  158 
RGS 19/10/18 0 244
19/10/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  244 
RGS 18/10/18 5 981
18/10/18 Last post  TDA Comments Created with Sketch.  5  Views Created with Sketch.  981 
RGS
Volume and price
2
17/10/18 93 22K
17/10/18 Last post  zeno9 Comments Created with Sketch.  93  Views Created with Sketch.  22K 
RGS 19/09/18 0 290
19/09/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  290 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Chinese patent granted for biomarkers for stem cell therapy
03 Dec 09:34
 
Results of Annual General Meeting
22 Nov 17:08
 
CEO Presentation to 2018 Annual General Meeting
22 Nov 14:12
 
Chairman's Address to Shareholders
22 Nov 14:06
 
Presentation for AusBiotech 2018
31 Oct 16:26
 
Re-Released - Appendix 4C - Quarterly
24 Oct 09:08
 
View More arrow Created with Sketch.
(20min delay)
Last
16.0¢
Change
0.00(0.00%)
Mkt cap $33.42M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 135762 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 23350 2
Last update - 16.12pm 18/01/2019 (20 minute delay) ?
(live)
Last
16.5¢
  Change
0.00 ( 0.00 %)
Open High   Low Volume
16.5¢ 16.5¢   16.5¢ 3250
Last updated 13.31pm 18/01/2019 (live) ?
RGS (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.